E1	Condition:T1 Name:T72
E2	Modifier:T2 Modifies:T127
E3	Or:T3 Arg:E2 Arg2:E4
E5	Provider:T5 Type:T73
E7	Condition:T7 Name:T74
E8	Exception:T8 From:E7 Except:E9
E9	Condition:T9 Name:T6
E10	Condition:T10 Name:T75
E11	Eq-Comparison:T11 Temporal-Period:T76
E12	Drug:T12 Name:T77 Temporality:E11
E13	Eq-Comparison:T13 Temporal-Period:T78
E14	Drug:T14 Name:T79 Temporality:E13
E15	Drug:T15 Name:T80 Temporality:E13
E16	Drug:T16 Name:T81 Temporality:E13
E17	Drug:T17 Name:T82 Temporality:E13
E18	Drug:T18 Name:T83 Temporality:E13
E19	Or:T19 Arg:E18 Arg2:E20
E20	Drug:T20 Name:T84 Temporality:E13
E21	Other:T21 Is-Other:E24
E22	Negation:T22 Negates:E23
E23	Condition:T23 Name:T85
E24	Condition:T24 
E25	Condition:T25 Name:T86
E26	Condition:T26 Name:T87
E27	Or:T27 Arg:E26 Arg2:E28
E28	Condition:T28 Name:T88
E29	Procedure:T29 Name:T90
E30	Temporal-Connection:T30 Arg:E29 Arg2:E31
E31	Study:T31 
E32	Other:T32 Is-Other:E33
E33	Study:T33 
E34	Or:T34 Arg:E33 Arg2:E36
E35	Eq-Comparison:T35 Temporal-Period:T91
E36	Drug:T36 Temporality:E35
E37	Eq-Comparison:T37 Temporal-Period:T92
E38	Drug:T38 Name:T93 Temporality:E37
E39	Drug:T39 Name:T94
E40	Or:T40 Arg:E39 Arg2:E41
E41	Drug:T41 Name:T95 Temporality:E37
E42	Eq-Comparison:T42 Temporal-Period:T96
E43	Drug:T43 Name:T97 Temporality:E42
E44	Drug:T44 Name:T98 Temporality:E42
E45	Drug:T45 Name:T99 Temporality:E42
E46	Drug:T46 Name:T100 Temporality:E42
E47	Drug:T47 Name:T101 Temporality:E42
E48	Drug:T48 Name:T102 Temporality:E42
E49	Drug:T49 Name:T103 Temporality:E42
E50	Drug:T50 Name:T104 Temporality:E42
E51	Drug:T51 Name:T105 Temporality:E42
E52	Drug:T52 Name:T106 Temporality:E42
E53	Drug:T53 Name:T107 Temporality:E42
E54	Drug:T54 Name:T108 Temporality:E42
E55	Drug:T55 Name:T109
E56	Drug:T56 Name:T110 Temporality:E42
E57	Drug:T57 Name:T111 Temporality:E42
E58	Drug:T58 Name:T112 Temporality:E42
E59	Drug:T59 Name:T113 Temporality:E42
E60	Drug:T60 Name:T114 Temporality:E42
E61	Drug:T61 Name:T115 Temporality:E42
E62	Drug:T62 Name:T116 Temporality:E42
E63	Or:T63 Arg:E62 Arg2:E64
E64	Drug:T64 Name:T117 Temporality:E42
E65	Condition:T65 Name:T118
E66	Eq-Comparison:T66 Value:T119 Operator:T120
E68	Observation:T68 Name:T121 Eq-Comparison:E69
E69	Eq-Comparison:T69 Operator:T122 Value:T123 Per:T129
E71	Observation:T71 Name:T124
E72	Procedure:T126 Name:T127 Provider:E5
E4	Modifier:T4 Modifies:T127
E6	Modifier:T67 Modifies:E66
E73	Temporal-Connection:T130 Arg:E68 Arg2:E74
E70	Observation:T70 Name:T125
E74	Study:T131 
T1	Condition 42 62	pseudoachondroplasia
T2	Modifier 102 111	in person
T3	Or 112 114	or
T5	Provider 141 170	skeletal dysplasia specialist
T7	Condition 183 190	Healthy
T8	Exception 191 197	beyond
T9	Condition 198 218	pseudoachondroplasia
T10	Condition 230 243	complications
T11	Eq-Comparison 270 277	Current
T12	Drug 285 296	resveratrol
T13	Eq-Comparison 302 309	Current
T14	Drug 317 331	blood thinners
T15	Drug 333 343	lovastatin
T16	Drug 345 357	ketoconazole
T17	Drug 359 371	itraconazole
T18	Drug 373 385	fexofenadine
T19	Or 386 389	and
T20	Drug 390 399	triazolam
T21	Other 406 411	Other
T22	Negation 412 415	non
T23	Condition 416 436	pseudoachondroplasia
T24	Condition 445 462	health conditions
T25	Condition 469 476	cancers
T26	Condition 483 492	Pregnancy
T27	Or 493 495	or
T28	Condition 496 509	breastfeeding
T29	Procedure 535 548	contraception
T30	Temporal-Connection 549 555	during
T31	Study 560 565	study
T32	Other 589 596	another
T33	Study 606 611	study
T34	Or 612 618	and/or
T35	Eq-Comparison 619 624	using
T36	Drug 625 647	investigational agents
T37	Eq-Comparison 654 657	Use
T38	Drug 661 690	Non-steroid anti-inflammatory
T39	Drug 692 698	NSAIDs
T40	Or 700 702	or
T41	Drug 703 710	aspirin
T42	Eq-Comparison 717 724	Current
T43	Drug 732 742	Alfentanil
T44	Drug 744 756	Cyclosporine
T45	Drug 758 775	Dihydroergotamine
T46	Drug 777 787	Dofetilide
T47	Drug 789 799	Ergotamine
T48	Drug 801 809	Fentanyl
T49	Drug 811 822	Flibanserin
T50	Drug 824 833	Oxycodone
T51	Drug 835 847	Pimavanserin
T52	Drug 849 857	Pimozide
T53	Drug 859 868	Quinidine
T54	Drug 870 880	Saquinavir
T55	Drug 882 891	Sirolimus
T56	Drug 893 903	Tacrolimus
T57	Drug 905 917	Temsirolimus
T58	Drug 919 931	Theophylline
T59	Drug 933 943	Tizanidine
T60	Drug 945 957	Thioridazine
T61	Drug 959 971	Fosphenytoin
T62	Drug 973 982	Phenytoin
T63	Or 983 985	or
T64	Drug 986 994	Warfarin
T65	Condition 1019 1023	pain
T66	Eq-Comparison 1027 1038	2 or higher
T68	Observation 1063 1077	Platelet count
T69	Eq-Comparison 1078 1097	below 50,000 per ul
T71	Observation 1110 1130	complete blood count
T72	Condition-Name 42 62	pseudoachondroplasia
T74	Condition-Name 183 190	Healthy
T75	Condition-Name 230 243	complications
T76	Eq-Temporal-Period 270 277	Current
T77	Drug-Name 285 296	resveratrol
T78	Eq-Temporal-Period 302 309	Current
T79	Drug-Name 317 331	blood thinners
T80	Drug-Name 333 343	lovastatin
T81	Drug-Name 345 357	ketoconazole
T82	Drug-Name 359 371	itraconazole
T83	Drug-Name 373 385	fexofenadine
T84	Drug-Name 390 399	triazolam
T85	Condition-Name 416 436	pseudoachondroplasia
T86	Condition-Name 469 476	cancers
T87	Condition-Name 483 492	Pregnancy
T88	Condition-Name 496 509	breastfeeding
T89	Life-Stage-And-Gender 511 516	Women
T90	Procedure-Name 535 548	contraception
T91	Eq-Temporal-Period 619 624	using
T92	Eq-Temporal-Period 654 657	Use
T93	Drug-Name 661 690	Non-steroid anti-inflammatory
T94	Drug-Name 692 698	NSAIDs
T95	Drug-Name 703 710	aspirin
T96	Eq-Temporal-Period 717 724	Current
T97	Drug-Name 732 742	Alfentanil
T98	Drug-Name 744 756	Cyclosporine
T99	Drug-Name 758 775	Dihydroergotamine
T100	Drug-Name 777 787	Dofetilide
T101	Drug-Name 789 799	Ergotamine
T102	Drug-Name 801 809	Fentanyl
T103	Drug-Name 811 822	Flibanserin
T104	Drug-Name 824 833	Oxycodone
T105	Drug-Name 835 847	Pimavanserin
T106	Drug-Name 849 857	Pimozide
T107	Drug-Name 859 868	Quinidine
T108	Drug-Name 870 880	Saquinavir
T109	Drug-Name 882 891	Sirolimus
T110	Drug-Name 893 903	Tacrolimus
T111	Drug-Name 905 917	Temsirolimus
T112	Drug-Name 919 931	Theophylline
T113	Drug-Name 933 943	Tizanidine
T114	Drug-Name 945 957	Thioridazine
T115	Drug-Name 959 971	Fosphenytoin
T116	Drug-Name 973 982	Phenytoin
T117	Drug-Name 986 994	Warfarin
T118	Condition-Name 1019 1023	pain
T119	Eq-Value 1027 1028	2
T120	Eq-Operator 1029 1038	or higher
T121	Observation-Name 1063 1077	Platelet count
T122	Eq-Operator 1078 1083	below
T123	Eq-Value 1084 1090	50,000
T124	Observation-Name 1110 1130	complete blood count
T125	Observation-Name 1132 1135	CBC
T126	Procedure 75 94	clinical assessment
T127	Procedure-Name 75 94	clinical assessment
T4	Modifier 118 137	photographic review
T73	Provider-Type 141 170	skeletal dysplasia specialist
T6	Condition-Name 198 218	pseudoachondroplasia
T67	Modifier 1042 1056	10 point scale
T129	Eq-Unit 1095 1097	ul
T130	Temporal-Connection 1098 1100	on
T70	Observation 1132 1135	CBC
T131	Study 1101 1109	baseline
A1	Temporal-Connection-Type-Value E30 during
A2	Eq-Temporal-Period-Value T76 present
A3	Eq-Temporal-Period-Value T78 present
A4	Life-Stage-And-Gender-Type T89 female
A5	Eq-Temporal-Period-Value T91 present
A6	Eq-Temporal-Period-Value T92 present
A7	Eq-Temporal-Period-Value T96 present
A8	Eq-Operator-Value T120 GTEQ
A9	Observation-Type-Value T121 lab
A10	Eq-Operator-Value T122 LT
A11	Observation-Type-Value T124 lab
A12	Temporal-Connection-Type-Value E73 during
R1	Found-By Arg1:E1 Arg2:E72
R2	Caused-By Arg1:E10 Arg2:E9
R3	Caused-By Arg1:E24 Arg2:E23
R4	Example-Of Arg1:E25 Arg2:E24
R5	If-Then Arg1:T89 Arg2:E29
R6	Abbrev-Of Arg1:E39 Arg2:E38
R7	Abbrev-Of Arg1:E70 Arg2:E71
R8	Using Arg1:E74 Arg2:E71
